A Pilot Study of Circulating MicroRNA-125b as a Diagnostic and Prognostic Biomarker for Epithelial Ovarian Cancer.
about
RNA-based ovarian cancer research from 'a gene to systems biomedicine' perspective.Prediction of therapy response in ovarian cancer: Where are we now?Ascites promotes cell migration through the repression of miR-125b in ovarian cancerThe role of MicroRNA molecules and MicroRNA-regulating machinery in the pathogenesis and progression of epithelial ovarian cancer.
P2860
A Pilot Study of Circulating MicroRNA-125b as a Diagnostic and Prognostic Biomarker for Epithelial Ovarian Cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A Pilot Study of Circulating M ...... for Epithelial Ovarian Cancer.
@en
A Pilot Study of Circulating M ...... for Epithelial Ovarian Cancer.
@nl
type
label
A Pilot Study of Circulating M ...... for Epithelial Ovarian Cancer.
@en
A Pilot Study of Circulating M ...... for Epithelial Ovarian Cancer.
@nl
prefLabel
A Pilot Study of Circulating M ...... for Epithelial Ovarian Cancer.
@en
A Pilot Study of Circulating M ...... for Epithelial Ovarian Cancer.
@nl
P2093
P2860
P921
P1476
A Pilot Study of Circulating M ...... for Epithelial Ovarian Cancer.
@en
P2093
Meijuan Wu
Ping Zhang
Shihua Wang
Ying Zhang
P2860
P356
10.1097/IGC.0000000000000846
P577
2016-09-15T00:00:00Z